Alpha 2.0
Login Register
» Authors » Therese M L Andersson

Therese M L Andersson

Explore the profile of Therese M L Andersson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 322
Followers 0
Related Specialties
Oncology
General Medicine
Hematology
Top 10 Co-Authors
Sandra Eloranta
Paul W Dickman
Paul C Lambert
Magnus Bjorkholm
Karin E Smedby
Ingrid Glimelius
Mats Jerkeman
Kamila Czene
Per Hall
Ola Landgren
Published In
Ann Intern Med
BMC Med Res Methodol
J Clin Oncol
Int J Cancer
Transfusion
Affiliations
Soon will be listed here.
Recent Articles
11.
Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer
Strand F, Humphreys K, Eriksson M, Li J, Andersson T, Tornberg S, et al.
Int J Cancer . 2016 Sep; 140(1):34-40. PMID: 27615710
Interval breast cancer (IC) has a more aggressive phenotype and higher mortality than screen-detected cancer (SDC). In this case-case study, we investigated whether the size of longitudinal fluctuations in mammographic...
12.
Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden
Lu D, Andersson T, Fall K, Hultman C, Czene K, Valdimarsdottir U, et al.
JAMA Oncol . 2016 Apr; 2(9):1188-96. PMID: 27124325
Importance: Psychiatric comorbidities are common among patients with cancer. However, whether or not there is increased risk of mental disorders during the diagnostic workup leading to a cancer diagnosis was...
13.
Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I, Ekberg S, Jerkeman M, Chang E, Bjorkholm M, Andersson T, et al.
Am J Hematol . 2015 Sep; 90(12):1128-34. PMID: 26349012
Trends in Hodgkin lymphoma (HL) survival among patients treated outside of clinical trials provide real-world benchmark estimates of prognosis and help identify patient subgroups for targeted trials. In a Swedish...
14.
Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006)
Eloranta S, Lambert P, Sjoberg J, Andersson T, Bjorkholm M, Dickman P
J Clin Oncol . 2013 Feb; 31(11):1435-41. PMID: 23439756
Purpose: Hodgkin lymphoma (HL) survival in Sweden has improved dramatically over the last 40 years, but little is known about the extent to which efforts aimed at reducing long-term treatment-related...
15.
Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models
Eloranta S, Lambert P, Andersson T, Czene K, Hall P, Bjorkholm M, et al.
BMC Med Res Methodol . 2012 Jun; 12:86. PMID: 22726307
Background: Relative survival is commonly used for studying survival of cancer patients as it captures both the direct and indirect contribution of a cancer diagnosis on mortality by comparing the...
16.
Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models
Andersson T, Dickman P, Eloranta S, Lambert P
BMC Med Res Methodol . 2011 Jun; 11:96. PMID: 21696598
Background: When the mortality among a cancer patient group returns to the same level as in the general population, that is, the patients no longer experience excess mortality, the patients...
17.
Should plasma from female donors be avoided? A population-based cohort study of plasma recipients in Sweden from 1990 through 2002
Tynell E, Andersson T, Norda R, Edgren G, Nyren O, Shanwell A, et al.
Transfusion . 2010 Feb; 50(6):1249-56. PMID: 20113457
Background: Plasma from female donors has been implicated in the sometimes fatal complication known as transfusion-related acute lung injury. In studies of patients in intensive care units, worsened gas exchange...